The allosteric AKT inhibitor, MK2206, decreases tumor growth and invasion in patient derived xenografts of endometrial cancer.
about
The allosteric AKT inhibitor, MK2206, decreases tumor growth and invasion in patient derived xenografts of endometrial cancer.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
The allosteric AKT inhibitor, ...... ografts of endometrial cancer.
@en
The allosteric AKT inhibitor, ...... ografts of endometrial cancer.
@nl
type
label
The allosteric AKT inhibitor, ...... ografts of endometrial cancer.
@en
The allosteric AKT inhibitor, ...... ografts of endometrial cancer.
@nl
prefLabel
The allosteric AKT inhibitor, ...... ografts of endometrial cancer.
@en
The allosteric AKT inhibitor, ...... ografts of endometrial cancer.
@nl
P2093
P2860
P1476
The allosteric AKT inhibitor, ...... ografts of endometrial cancer.
@en
P2093
Abigail Winder
J Julie Kim
John Lurain
Kenji Unno
P2860
P304
P356
10.1080/15384047.2017.1281496
P577
2017-01-23T00:00:00Z